JP2011507880A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507880A5
JP2011507880A5 JP2010539775A JP2010539775A JP2011507880A5 JP 2011507880 A5 JP2011507880 A5 JP 2011507880A5 JP 2010539775 A JP2010539775 A JP 2010539775A JP 2010539775 A JP2010539775 A JP 2010539775A JP 2011507880 A5 JP2011507880 A5 JP 2011507880A5
Authority
JP
Japan
Prior art keywords
patients
years
treated
chlorambucil
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539775A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/087336 external-priority patent/WO2009082662A1/en
Publication of JP2011507880A publication Critical patent/JP2011507880A/ja
Publication of JP2011507880A5 publication Critical patent/JP2011507880A5/ja
Pending legal-status Critical Current

Links

JP2010539775A 2007-12-21 2008-12-18 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤 Pending JP2011507880A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1570407P 2007-12-21 2007-12-21
PCT/US2008/087336 WO2009082662A1 (en) 2007-12-21 2008-12-18 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014115061A Division JP2014177487A (ja) 2007-12-21 2014-06-03 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤

Publications (2)

Publication Number Publication Date
JP2011507880A JP2011507880A (ja) 2011-03-10
JP2011507880A5 true JP2011507880A5 (cg-RX-API-DMAC7.html) 2012-01-26

Family

ID=40352369

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539775A Pending JP2011507880A (ja) 2007-12-21 2008-12-18 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤
JP2014115061A Pending JP2014177487A (ja) 2007-12-21 2014-06-03 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014115061A Pending JP2014177487A (ja) 2007-12-21 2014-06-03 慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤

Country Status (7)

Country Link
US (2) US20110028422A1 (cg-RX-API-DMAC7.html)
EP (1) EP2240172B1 (cg-RX-API-DMAC7.html)
JP (2) JP2011507880A (cg-RX-API-DMAC7.html)
ES (1) ES2459877T3 (cg-RX-API-DMAC7.html)
PL (1) PL2240172T3 (cg-RX-API-DMAC7.html)
PT (1) PT2240172E (cg-RX-API-DMAC7.html)
WO (1) WO2009082662A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425830A1 (en) * 2010-09-03 2012-03-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synergistic drug combination for the treatment of cancer
US20150182490A1 (en) 2012-06-26 2015-07-02 Del Mar Pharmaceuticals Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
CN105492011A (zh) 2013-04-08 2016-04-13 丹尼斯·M·布朗 不理想给药化学化合物的治疗增效
CA2941632C (en) * 2014-03-13 2023-10-24 Vasilios VOUDOURIS Bendamustine solid dispersions and continuous infusion
US9777572B2 (en) * 2014-11-17 2017-10-03 Baker Hughes Incorporated Multi-probe reservoir sampling device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3046301A (en) 1959-10-29 1962-07-24 Burroughs Wellcome Co Method of making chlorambucil
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
ATE468855T1 (de) 2002-11-12 2010-06-15 Jewish General Hospital Kombination von stickstoff-senf analogen und imatinib für die behandlung von chronischer lymphatischer leukämie
GT200600315A (es) 2005-07-20 2007-03-19 Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida

Similar Documents

Publication Publication Date Title
Esquirol et al. Shift work and cardiovascular risk factors: new knowledge from the past decade
PH12012502226A1 (en) Il-1 binding proteins
CA2863393A1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
WO2009137807A3 (en) Compositions and methods related to mirna modulation of neovascularization or angiogenesis
WO2009152484A3 (en) Methods and platforms for drug discovery
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
WO2007061906A3 (en) Diagnostic and therapeutics for cardiovascular disorders
Bobińska et al. The role of MMP genes in recurrent depressive disorders and cognitive functions
EP2532748A3 (en) DNA aptamer specifically binding to human cardiac troponin I
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2010004283A3 (en) Sulfonylurea receptor and means for treating ischaemia
FI20115670A0 (fi) Kardiovaskulaarinen in vitro-malli
WO2011133036A3 (en) Means and methods for determining risk of cardiovascular disease
JP2012506031A5 (cg-RX-API-DMAC7.html)
WO2013066879A3 (en) SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE
Leone Patterns and composition of weight change in college freshmen
WO2014117680A3 (zh) 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆
Wu et al. Nuclear Translocation of β‐Catenin Mediates the Parathyroid Hormone‐Induced Endothelial‐to‐Mesenchymal Transition in Human Renal Glomerular Endothelial Cells
Bose et al. P. 2. e. 016 Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial
ATE523602T1 (de) Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen
Shavva et al. Proliferation of activated hepatic stellate cells requires REST
JP2010502179A5 (cg-RX-API-DMAC7.html)
EP1773762A4 (en) METHODS AND COMPOUNDS FOR DETECTING MEDICAL DISORDERS
AR080471A1 (es) Participacion de la via de androgenos/receptores de androgenos en la enfermedad de fabry